Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: alan laValley who wrote (18384)	1/29/1999 9:12:00 PM
From: Zebra 365	Respond to of 23519

Has anyone considered the possibility of an OTC product? With the safety profile of MUSE, (except for sickle cell patients), and the side-effect profile.... This could be an OTC drug, throw some "herbal" in and it would sell. Just a thought for discussion, obviously the stock is nothing to get excited about at this point. Zebra

To: alan laValley who wrote (18384)	1/29/1999 9:12:00 PM
From: DaiS	Read Replies (2) \| Respond to of 23519

Alan, I don't know big business...is it really poker? If Vivus was simply a manufacturing plant for muse, still I do not believe that Astra/J&J would want to screw and ruin Vivus. There is no gurantee that they would be the ones to pick up the pieces for peanuts? But Vivus have Alibra coming fairly soon? What about Astra selling muse in Europe and Eli Lilly selling Alibra in Europe? And some one else developing the gene therapy? I think Leland does have a few cards to play....an inept manager could always be a good poker player!? DaiS